metastatic colorectal cancer

39 total trials 20 recruiting

Filter these 39 trials by phase, country, sponsor and more.

Open in Search →

VINORELBINE INHIBITS ONCOGENIC FUNCTIONS OF MKK3: A NEW THERAPEUTIC OPPORTUNITY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER Pending

2024-519459-27-00 4
A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizu … Pending

2025-521587-35-00 5
Impact of Biweekly and Triweekly Dosing Regimens Pending

2025-522305-38-00 4
Use of the chemotherapy FOLFIRI and cetuximab if given with treatment breaks or continuously in patients with newly diagnosed metastatic col … Pending

2025-522377-12-00 5
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorect … Pending

2025-523521-18-00 5
Upfront trastuzumab-deruxtecan plus capecitabine and bevacizumab for patients with HER2 positive metastatic colorectal cancer: the CHIMERA t … Recruiting

2024-519479-24-00 4 2025-11-21
Phase III study in first-line treatment of patients with metastatic colorectal cancer who are not candidate for intensive therapy. (SOLSTICE … Recruiting

2024-516180-85-00 5 2019-04-15
ROMANCE Recruiting

2025-521319-38-00 4 2026-03-11
A clinical study to test if an investigational treatment called BNT314 when used in combination with another investigational treatment pumit … Recruiting

2025-521768-36-00 9 2026-01-27
Clinical performance study of a new diagnostic test for drug sensitivity evaluation in metastatic colorectal cancer Recruiting

2024-519600-27-00 4 2025-10-28
CAPRI-3 Phase 3 clinical study to evaluate the use of continuing cetuximab treatment beyond first line progression in molecular selected met … Recruiting

2024-519322-20-00 5 2025-07-21
A Study to Assess the Adverse Events and Change in Disease Activity of Multiple Treatment Combinations with Telisotuzumab Adizutecan in Part … Recruiting

2024-512981-33-00 4 2025-07-09
A Phase 1b/2 study of arfolitixorin as part of 5-fluorouracil-based treatment regimens in the first-line treatment of metastatic colorectal … Recruiting

2024-516802-43-00 9 2025-04-09
Sequential immunochemotherapy treatment with Pembrolizumab plus Dendritic Cell (DC) Vaccine followed by Trifluridine/Tipiracil plus Bevacizu … Recruiting

2024-514053-30-00 4 2025-01-07
The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET) Recruiting

2024-512301-16-01 3 2024-12-12
PHASE III RANDOMIZED STUDY OF FOLFOXIRI PLUS BEVACIZUMAB AND ATEZOLIZUMAB VERSUS FOLFOXIRI PLUS BEVACIZUMAB AS FIRST-LINE TREATMENT OF UNRES … Recruiting

2023-506632-32-00 5 2024-10-28
DOSAgE study: A multicenter randomized phase III trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older patients Recruiting

2023-506115-17-00 5 2024-10-14
CARE : Impact of Regorafenib in combination with multimodal metronomic chemotherapy (cyclophosphamide, capecitabine, and low-dose aspirin) o … Recruiting

2023-509761-21-00 5 2024-07-08
Bevacizumab plus encorafenib-cetuximab in BRAF-V600E mutated metastatic colorectal cancer, a phase II study with a safety lead-in cohort, th … Recruiting

2023-509204-15-00 4 2024-05-17
Nivolumab and ipilimumab in patients with dMMR and/or MSI metastatic colorectal cancer resistant to anti-PD1 monotherapy: An open-label phas … Recruiting

2024-516313-20-00 4 2022-04-19
Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418). Prospective, randomized, … Recruiting

2024-512174-10-00 5 2021-11-11
Prospective, randomized, open, multicenter Phase II trial to investigate the efficacy of trifluridine/tipiracil plus panitumumab versus trif … Recruiting

2024-513723-16-00 4 2021-10-21
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC) Recruiting

2023-505163-37-00 3 2021-10-01
Investigate the efficacy and safety of a bio-marker driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RA … Recruiting

2024-518534-81-00 4 2021-07-01

Showing 1–24 of 39 trials